-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Defect of alveolar regeneration in pulmonary emphysema: Role of lung fibroblasts
(2062) Views (446) Full article downloads
Authors: Laurent Plantier, Jorge Boczkowski, Bruno Crestani
Published Date January 2007
Volume 2007:2(4) Pages 463 - 469
DOI: http://dx.doi.org/10.2147/COPD.S
Laurent Plantier1,2, Jorge Boczkowski1,3, Bruno Crestani1,4
1INSERM, U700, Faculté Xavier Bichat, Paris, France; 2Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Service de Pneumologie B, Paris, France; 3Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, CIC 07, Paris, France; 4Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Service de Pneumologie A, Paris, France
Abstract: Pulmonary emphysema is characterized by the irreversible loss of pulmonary alveoli. Despite recent advances in the understanding this disease, its treatment remains palliative. In this review, we will successively review the data suggesting (1) that alveolar regeneration systems are functional in the mammalian lung and have the potential to regrow lost alveoli, (2) that cigarette smoke, the main etiologic factor of emphysema, inhibits those systems under experimental conditions, and (3) that alveolar regeneration systems are dysfunctional in the human emphysematous lung and may be a target for therapeutic intervention in this disease. Special emphasis will be put on the role of alveolar fibroblasts in those processes.
Keywords: emphysema, repair, regeneration, HGF, fibroblasts
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




